CancerCompass message board discussion started by Terrilynn on 1/3/2007 http://www.cancercompass.com/message-board/message/all,8600,0.htm Wed, 08 Oct 2008 00:00:00 GMT Wed, 08 Oct 2008 00:00:00 GMT http://backend.userland.com/rss RSS.NET: http://www.rssdotnet.com/ Thanks for your information on ET. I was wondering if you knew if there is a trail drug on the market for ET? If so do your numbers have to be at  a certain level before you can go on it? Thanks again. Terri Terrilynn Wed, 03 Jan 2007 00:00:00 GMT Various medications may be used to reduce platelets, including hydroxyurea, anagrelide, interferon and busulfan. Each medication is associated with its own side effects, and treatment needs to be tailored to each patient. No single treatment method works for all patients.  Views differ on who/when to treat ET patients. Generally patients can be grouped as  low risk, intermediate risk and high risk. Low risk patients are those under 60 with a platelet count under 1.5 million who do not have a history of thrombosis and do not have cardiovascular risk factors.  In that case you may not even need treatment or just a daily aspirin. Oncrx Thu, 04 Jan 2007 00:00:00 GMT